SAN FRANCISCO, May 22, 2025 /PRNewswire/ -- OncoSwab, a biotechnology company focused on early detection of cancer through non-invasive molecular testing, today announced it has entered into a ...
TipRanks on MSN
Relmada’s BOOST phase 3 bladder cancer trial sets up a new catalyst for RLMD investors
Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...
Scientists studied factors such as viral infections, gut microbiome, and exposome that could drive cancers, as well as how to ...
GRAND RAPIDS, MI – Greg Allushuski, 81, has undergone months of harsh and invasive cancer treatments, including chemotherapy, radiation and surgery, since he was diagnosed with cancer a ...
Landmark trials have driven a shift from radical mastectomies to less invasive, breast-conserving surgeries. Non-invasive breast carcinomas, when detected early, have highly favorable survival and ...
A research team led by Dr. Ho Sang Jung of the Advanced Bio and Healthcare Materials Research Division at the Korea Institute of Materials Science has developed an innovative sensor material that ...
Two applicants will each receive a Grant of $50,000 to support the development of outstanding clinical cancer research to improve the treatment of NMIBCApplications for the fellowship are due on ...
Researchers identify APOC1 and NOP16 as promising prostate cancer biomarkers that could aid early diagnosis. Learn more about ...
Hosted on MSN
Wearable patch detects cancer in sweat
Innovative advancements in technology have sparked a new era in cancer detection, with wearable patches that can identify signs of cancer in sweat leading the way. This groundbreaking technology ...
Imagine tiny machines, smaller than a virus, spinning inside cancer cells and rewiring their behavior from within. No surgery, no harsh chemicals, just precision at the molecular level. Two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results